BKM120上海阿拉丁生化科技股份有限公司阿拉丁中国BKM120 (NVP-BKM120, Buparlisib)是一种选择性PI3K抑制,作用于p110α/β/δ/γ时,IC50分别为52 nM/166 nM/116 nM/262 nM
阿拉丁上海 分子式 C18H21F3N6O2
Buparlisib HydrochlorideMedChemExpress (MCE)美国Buparlisib Hydrochloride (BKM120 Hydrochloride) 是一种 pan-class I PI3K 抑制剂
BuparlisibTargetMol美国生化试剂,可用于动物细胞实验Product IntroductionBioactivity英文名: Buparlisib描述: Buparlisib (BKM120) 是一种具有口服生物利用度的泛
BuparlisibMedChemExpress (MCE)美国Buparlisib (BKM120; NVP-BKM120) 是一种 pan-class I PI3K 抑制剂,作用于 p110α/p110β/p110δ/p110
值分别为 0.1 uM 和 40 nM。激酶实验: PI3K biochemical assay (ATP depletion assay): BKM120 is dissolved in DMSO and directly
at the daily dose of 3.75 and 7.5 mg/kg relative to BKM120 at the dose of 15 and 30 mg/kg.存储条件: Powder: -20°C for 3 years
in combination with BKM120, VX-11e results in significantly improved tumor growth inhibition. [2]存储条件: Powder: -20°C for 3 years
in NSG mice bearing human melanoma RPDX tumors. VX-11e with BKM120 significantly improves tumor growth inhibition.相关产品
沃特世美国 通过产品的QC测试可知,要满足具有添加营养价值的新产品需求,食品厂商面临着严峻的挑战。沃特世可以通过标准
祝贺!第十五届光华工程科技奖获奖名单公布,这41名专家获奖
创新引领未来 | 安捷伦智能化气相色谱新品重磅发布
安捷伦在ASMS:智能推动性能 挑战极限应用
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net